Wells Fargo’s Nutraceutical International Co NUTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-6,046
Closed -$252K 6653
2017
Q2
$252K Buy
6,046
+124
+2% +$4.42K ﹤0.01% 4644
2017
Q1
$184K Hold
5,922
﹤0.01% 4870
2016
Q4
$207K Buy
5,922
+2,161
+57% +$68.5K ﹤0.01% 4754
2016
Q3
$117K Hold
3,761
﹤0.01% 4821
2016
Q2
$87K Sell
3,761
-5,322
-59% -$127K ﹤0.01% 4915
2016
Q1
$222K Buy
9,083
+6,429
+242% +$156K ﹤0.01% 4345
2015
Q4
$68K Buy
2,654
+919
+53% +$22.6K ﹤0.01% 5156
2015
Q3
$41K Sell
1,735
-85
-5% -$2.03K ﹤0.01% 5331
2015
Q2
$45K Buy
1,820
+1,369
+304% +$28.9K ﹤0.01% 5358
2015
Q1
$9K Buy
451
+50
+12% +$941 ﹤0.01% 5677
2014
Q4
$9K Buy
401
+3
+0.8% +$65 ﹤0.01% 5699
2014
Q3
$8K Sell
398
-280
-41% -$6.52K ﹤0.01% 5698
2014
Q2
$16K Buy
+678
New +$16.6K ﹤0.01% 5481

Wells Fargo's NUTR Position: Q3 2017 in Review

Wells Fargo sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 6,046 shares — an estimated $252K sold.

Wells Fargo first reported a position in NUTR in Q2 2014 and held it in 13 quarters. The position peaked at $252K in Q2 2017. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.

  • Wells Fargo reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
  • Wells Fargo sold 6,046 Nutraceutical International Co shares in Q3 2017, an estimated $252K.
  • Wells Fargo first reported a position in Nutraceutical International Co in Q2 2014 and held it in 13 quarters.
  • Wells Fargo's Nutraceutical International Co position peaked at $252K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.

Based on Wells Fargo's 13F filing for Q3 2017, filed 9 Nov 2017.